Wockhardt share price is up by 0.73% on NSE today. Wockhardt is a global pharmaceutical and biotechnology company, offering high-quality, affordable medicines with a goal of making the world healthier. It is India’s leading research-based healthcare enterprise operating in the fields of biotechnology, pharmaceuticals and a chain of modern Super Speciality Hospitals.
Wockhardt has a multi-ethnic workforce of 8600 hailing from 21 odd countries globally. It encapsulates twelve manufacturing plants and three research centres, with businesses extending from the manufacture and marketing of Active Pharmaceutical Ingredients, bio-pharmaceutical and pharmaceutical vaccines and formulations.
New Wockhardt. Novel way of innovation and thinking
It is a business in transition. Innovative and fresh business models are like a cog making the most of emerging opportunities. A novel drive for growth today permeates every mindset, process and innovation in technology within Wockhardt.
Wockhardt looks at fresh new ways of thinking, ideating, working and touching the life of the common man.
Growing around the world
Wockhardt has its headquarters in Mumbai. It has full-fledged operations in the USA, France, UK and Ireland. The company is also present in developing markets of Russia, Nigeria, Ghana, Tanzania, Mexico, Brazil, Philippines, Myanmar, Mauritius, Sri Lanka, Vietnam, Kenya, Nepal, Uganda, Kuwait and Lebanon.
Wockhardt Share price performance
Currently Wockhardt share price is trading at Rs.920.15, up by 0.58% (NSE). It opened at Rs.923. According to Dynamic Research team, Wockhardt ranks amongst the Top 500 Shares out of 1700 Shares of NSE, identified at the end of every quarter.
Research and development
Wockhardt is defined by a single word “innovation”. It makes use of science and technology to produce medicines and other products that improve the quality of health of a million.
It has a program with more than 607 scientists, encompassing more than 80 doctorates, in fields of:
Research on Pharmaceuticals
Research on Biotechnology & Genomics
Fresh New Drug Delivery Systems
Innovative and Novel Drug Discovery Program. API Research
CSR
Wockhardt Foundation has touched three million lives through its various medical programs, social awareness, human values, social development and other initiatives.
Its vision – ‘More & More with Less & Less’ has resulted in brand new ways of thinking and ideating, a brand new journey for medical breakthroughs and consistent value for stakeholders.
For more details on Wockhardt, visit Wockhardt Share Price Forecast.
Description: Wockhardt share price is up by 0.73% on NSE today. It is a pharmaceutical and biotechnology company, offering high-quality, affordable medicines.
Dynamic Levels 